Cointime

Download App
iOS & Android

Protalix BioTherapeutics

company
Funding Round
Post-IPO Equity
Money Raised
$ 43.70M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
UBS O'Connor - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
Oct 14, 2015 Post-IPO Equity $ 10M Pfizer Detail